Subcutaneous Drug Delivery Market

Subcutaneous Drug Delivery Market

Category : Healthcare & Life Sciences Reports | Delivery Format : PDF,PPT | Publisher: Reports and Insights | Pages : XXX

Subcutaneous Drug Delivery Market

To learn more about this report, request a free sample copy

Subcutaneous Drug Delivery Market Overview

The report is titled as ‘Subcutaneous Drug Delivery Market: Opportunity Analysis and Future Assessment 2022-2030’. An overview of conceptual frameworks, analytical approaches of the Subcutaneous Drug Delivery market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market. Subcutaneous Drug Delivery market is expected to grow with significant rate in the near future.

The subcutaneous drug delivery market is estimated to reach at a value of US$ 11,743.0 Mn by the end of 2022 and expected to reach at a value of US$ 23,773.7 Mn by 2030 with a significant CAGR of 9.2%.

Subcutaneous Drug Delivery Introduction

The subcutaneous drug delivery are the simpler and effective forms of injecting drugs that are usually injected in the cutis layer of the skin that is included in the epidermis as well as dermis layer of the skin. This form of drug delivery is generally preferred over intravenous administration of drugs as it cost-effective. These comprises of the prefilled syringes that are disposable as well as ready-to-use which helps in the reduction of the dosing mistakes and increases patient compliance, dosing accuracy, convenience, and safety. These make use of the single injector device, auto injector, mechanical pumps that helps in the progression of the digital medicine.

The advent of the biologics is attributing to the increased demand for subcutaneous drug delivery which is fostering the growth of the market. Due to the technological advancements such as bluetooth connectivity in glucometer as well as the feature of touch screen that is further propelling the growth of the market.

Moreover, the usage of the subcutaneous route of administration is effective in comparison to the intravenous route of administration. Hence, the increasing demand of subcutaneous drug delivery devices is increasing the growth of subcutaneous drug delivery market in the forthcoming future.

Subcutaneous Drug Delivery Market Segmentation

The subcutaneous drug delivery market is segmented on the basis of product type, usability, disease indication, delivery type, distribution channel, and region

By Product Type

Fillable Injectable

Prefilled Injectable

By Usability

Disposable

Reusable

By Technology

Jet

Spring

Gas

By Disease Indication

Auto-immune Disorders

Neurological Disorders

Oncology Disorders

Hormonal Disorders

Allergy & Infectious Disorders

Ophthalmic Disorders

Others

By Delivery Type

Prefilled Syringe

Auto-injector

Spring Type

Motorized Type

Wearable Type

Prefilled Pen

Vial (Syringe)

Pump

Others

By Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

By Region

North America

Latin America

Asia Pacific

Europe

Middle East

Africa

Subcutaneous Drug Delivery Market Key Players

Some of the key participating players in global subcutaneous drug delivery market are:

Becton Dickinson Company

Consort Medical

West pharmaceuticals services Inc.

Ypsomed AG

Elcam Medical

Sc Pharmaceuticals Inc.

Steady Med Ltd

Amgen Inc.

Sensile medical AG

Factors that are benchmarked while estimating the market

Various factors that are benchmarked while estimating the market growth includes (but not restricted to):

New product designs and launches

Current product compliance

Reimbursement

Concerns for use of Subcutaneous Drug Delivery

Advantages of Subcutaneous Drug Delivery

Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to take informed decision.

A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s product sales, previous growth rates and market expansion plans are considered to generate market share in the market.


To learn more about this report, request a free sample copy


Select License Type

Frequently Asked Questions

The subcutaneous drug delivery market is estimated to reach at a value of US$ 11,743.0 Mn by the end of 2022 and expected to reach at a value of US$ 23,773.7 Mn by 2030 with a significant CAGR of 9.2%.

The base year for the report is 2021 in subcutaneous drug delivery market.

The global subcutaneous drug delivery market is segmented on the basis of product type, usability, disease indication, delivery type, distribution channel, and region

Becton Dickinson Company, Consort Medical, West pharmaceuticals services Inc., Ypsomed AG, Elcam Medical, Sc Pharmaceuticals Inc., Steady Med Ltd, Amgen Inc. and Sensile medical AG



This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy

OK